Modulation of the tumour promoting functions of cancer associated fibroblasts by phosphodiesterase type 5 inhibition increases the efficacy of chemotherapy in human preclinical models of esophageal adenocarcinoma
Annette Hayden(Southampton General Hospital), Tim Underwood(Southampton General Hospital)
Cited by 2
Related Papers
Cancer‐associated fibroblasts predict poor outcome and promote periostin‐dependent invasion in oesophageal adenocarcinoma
|The Journal of Pathology|2014|182
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial
|The Lancet. Gastroenterology & hepatology|2019|64
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
|Gut|2019|27